Erlotinib overcomes paclitaxel-resistant cancer stem cells...

Oncogenesis 2019 / 12 Vol. 8; Iss. 12

Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer

Lv, Yaping, Cang, Wei, Li, Quanfu, Liao, Xiaodong, Zhan, Mengna, Deng, Huayun, Li, Shengze, Jin, Wei, Pang, Zhi, Qiu, Xingdi, Zhao, Kewen, Chen, Guoqiang, Qiu, Lihua, Huang, Lei
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Journal:
Oncogenesis
DOI:
10.1038/s41389-019-0179-2
Date:
December, 2019
File:
PDF, 2.04 MB
2019
Conversion to is in progress
Conversion to is failed